Akamatsu H, Teraoka S, Takamori S, Miura S, et al. Nivolumab Retreatment in Non-Small Cell Lung Cancer Patients Who Responded to Prior Immune Checkpoint Inhibitors and Had ICI-Free Intervals (WJOG9616L). Clin Cancer Res 2022 Jun 28:OF1-OF7. doi: 10.1158/1078-0432.CCR-22-0602.
PMID: 35762926